MedPath

Ultrasound Guided Quadratus Lumborum Block Versus Transversus Abdominis Plane Block as Postoperative Analgesia in Patients Undergoing Abdominal Cancer Surgery.

Phase 3
Recruiting
Conditions
Abdominal Cancer
Registration Number
NCT05533424
Lead Sponsor
Mansoura University
Brief Summary

Abdominal surgery is usually associated with severe postoperative pain. The transverse abdominal plane (TAP) block is considered an effective means for pain control in such cases. The quadratus lumborum (QL) block is another option for the management of postoperative pain.

The aim of this study is to evaluate the efficacy and safety of quadrates lumborum blocks and Transversus abdominis plane blocks for pain management after abdominal cancer surgery.

Detailed Description

Postoperative pain is severe in patients undergoing abdominal surgery, and severe pain not only affects the rate of recovery of patients but also induces a series of pathophysiological reactions. Therefore, it is very important for perioperative patients to have a safe and effective pain management model. Although classic postoperative analgesia methods can provide effective pain relief after surgery, their administration has a well-defined risk of side effects. Recently, with the rise in enhanced recovery after surgery, nerve blocks have become the key link in multimodal analgesic regimes.

As effective constituents of multimode analgesia, quadratus lumborum (QL) block and transversus abdominis plane (TAP) block are mainly used for postoperative analgesia in abdominal surgery.

Aim of this study is to compare between the analgesic effecacy of quadrates lumborum block and transverses abdominal plane block

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
98
Inclusion Criteria
  • Patients included in the study, aged 20-60 years,
  • with ASA Physical Status Class I and II,
  • scheduled for abdominal cancer surgery under general anesthesia
Exclusion Criteria
  • infection at injection site,
  • allergy to local anesthetics,
  • coagulation disorders,
  • physical or mental diseases which could interfere with the evaluation of pain scores
  • kidney failure or liver failure.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The total dose of morphinein the first 24 hours after surgery

amount of morphine in mg

Secondary Outcome Measures
NameTimeMethod
visual analog scorepostoperatively at 24 hours

ranging from 0 to 10, where 0 no pain and 10 maximum pain

Trial Locations

Locations (1)

Nevert Adel Abdel Ghaffar

🇪🇬

Mansoura, Egypt

Nevert Adel Abdel Ghaffar
🇪🇬Mansoura, Egypt
Nevert A Abdel Ghaffar, MD
Contact
01223947977
nevertadel@mans.edu.eg
Yahya M Wahba, MD
Contact
01211313554
yahyawahba@ymail.com
nevert a abdel ghaffar, assist prof
Sub Investigator
ghada f amer, assist prof
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.